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O10.6 How many psychiatric beds per capita do we need?
Richard O'Reilly*1, John Gray1, Jerry Shum1
1University of Western Ontario, Faculty of Medicine, Ontario, Canada
Background: Since the 1950s, psychiatric services in most developed
countries have undergone radical change from a system almost
exclusively hospital-based to one that now operates primarily in
community settings. The decline in the absolute number of psychiatric
beds has been accentuated by signiﬁcant population expansion in
many countries. As bed numbers have decreased, there are fewer beds
available to treat people experiencing acute exacerbations of schizo-
phrenia and other psychotic illnesses. Few attempts have been made to
identify a minimal or optimal number of psychiatric beds per capita.
Many administrators reasonably contend that the optimal number of
psychiatric beds depends on the quantity and quality of the community
psychiatric services. However, we should at least have a range for the
required minimum and optimum number of beds in a similar way that
we have for other elements of the service system such as numbers of
psychiatrists and community-based teams. In this study, we make our
ﬁrst attempt to put parameters around what these ranges might be.
Methods: We extracted reported psychiatric bed numbers for nations
in the databases of the World Health Organization and the
Organization for Economic Cooperation and Development. The
Canadian data from the above databases was ﬁrst veriﬁed using data
in the Canadian Institute for Health Information (CIHI) database. We
further veriﬁed the Canadian data, which is hospital speciﬁc, by
contacting each hospital in three Canadian provinces. We established
the cause of all noted inconsistencies in hospital speciﬁc data. These
procedures identiﬁed several areas that are likely to be a source of
confusion when comparing data within and between jurisdictions.
Finally, we polled Canadian jurisdictions to determine if there were
established targets for psychiatric beds.
Results: Remarkable variation exists in bed numbers amongst similar
nations. Germany, Canada and Italy have respectively 87, 35, and 10
psychiatric beds/100,000 population. We will focus our further analysis
on these three nations as representative examples of countries with a
high, medium and, low rate of psychiatric beds per capita. The initial
due diligence comparison of the CIHI data with ﬁgures obtained
directly from hospitals yielded hospital speciﬁc differences as great as
20%. Uncertainty over whether to include beds used for detoxiﬁcation
and those used for more formal addictions treatment accounted for
much of these variances. In Canada, only the province of Ontario has
established a psychiatric bed target (35/100,000). In contrast, the
Canadian Psychiatric Association recommended 50 acute beds and 15
long-stay beds/100,000.
Discussion: Countries with similar levels of development appear to
have markedly differing amounts of inpatient services for people with
psychiatric disorders. We are currently undertaking a more detailed
analysis of the types of services included in the reported bed numbers
in Germany and Italy to ensure that they are comparable with Canada.
In view of the degree of the variances found thus far, it seems likely
that there are real differences. If there are, it would raise important
questions of how Italy manages the types of individual who are
treated as inpatients in Germany and Canada and whether the
outcomes are equivalent.
O10.7 An investigation of the potential speciﬁcity of childhood
maltreatment trauma in patients with non-affective psychosis as
compared to other mental health disorders
Nina Mørkved*1, Mathilde Endsjø2, Dagﬁnn Winje2, Erik Johnsen3, Anders Dovran4,
Kjersti Arefjord2, Rune Kroken3, Siri Helle5, Liss-Gøril Anda-Ågotnes6, Maria
Rettenbacher7, Nathalie Huber7, Else-Marie Løberg8
1Mosjoen District Psyciatric Centre, Helgeland Hospital, 2University of
Bergen, Bergen, Norway, 3University Hospital; University of Bergen,
4University of Bergen; Sørlandet Hospital Health Enterprise, 5Haukeland
University Hospital, Bergen, Norway, 6Stavanger University Hospital,
Stavanger, Norway, 7Innsbruck Medical University, Innsbruck, Austria,
8University of Bergen; Haukeland University Hospital
Background: Childhood maltreatment trauma (CMT) might be a
potential risk factor in psychosis, and the prevalence of CMT may be
higher in patients with psychosis as compared to other mental health
disorders. However, research also shows an increase in general
psychopathology and a variety of mental health disorders following
CMT, raising the question of speciﬁcity between CMT and psychotic
disorders. The aim of the study was to investigate the potential
speciﬁcity of CMT in psychosis. We hypothesized that there would be
more CMT in patients with non-affective psychosis as compared to
other mental health disorders.
Methods: The sample consisted of 52 patients with non-affective
psychosis and 52 matched patients with other mental health
disorders. All patients in the psychosis group (n= 52) met the
ICD-10 diagnostic criteria for non-affective psychosis (F20–F29;
Schizophrenia, schizotypal, and delusional disorders), and had a score
of&4 on at least one of the items Delusions, Hallucinatory behavior,
Grandiosity, Suspiciousness/Persecution, or Unusual thought content
on the PANSS. The non-psychosis group consisted of ICD-10 diagnosis
F10–19 Mental and behavioral disorders due to psychoactive
substance use, F30–39 Mood disorders, F40–48 Neurotic, stress-
related and somatoform disorders, F50–59 Behavioral syndromes
associated with physiological disturbances and physical factors, F60–
69 Disorders of adult personality and behavior, and F80–89 Disorders
of psychological development. CMT was measured by the Childhood
Trauma Questionnaire Short-Form (CTQ-SF) assessing physical, emo-
tional and sexual abuse, and physical and emotional neglect. We
compared the two groups on CTQ-SF sum score and subscale scores
indicating rates of CMT, in addition to rates of none/low vs. moderate/
severe levels of CMT.
Results: The psychosis group had signiﬁcantly higher CTQ-SF sum
scores U=893.50, P= 0.003, r=− 0.29, and scored signiﬁcantly higher
on three of ﬁve subscales; physical abuse, U= 1069.50, P= 0.039,
r=− 0.20, sexual abuse, U= 1043.50, P=0.004, r=− 0.28, and physical
neglect, U=773.50, P=0.000, r=− 0.38. Patients in the psychosis
group were more likely to have experienced moderate/severe levels of
CMT. Emotional neglect and emotional abuse were no more frequent
in the psychosis group than in the non-psychosis group. In the
psychosis group, 67.3% had cut-off scores for one or more subtypes of
CMT as compared to 38.5% in the non-psychosis group, and 9.6% had
cut-off scores for four or more subtypes of CMT compared to 0% in
the non-psychosis group.
Discussion: Patients with psychosis reported a history of more CMT,
both in terms of severity and frequency, compared to non-psychotic
patients. Thus, our results mainly conﬁrmed our hypothesis of a link
between CMT and psychosis. However, the prevalence of some CMT
also in the non-psychosis group, as well as non-signiﬁcant differences
in two subtypes of CMT indicated a graded speciﬁcity of CMT in
psychosis. Our results are consistent with previous research on CMT
and psychosis. Limitations regarding the present study relate to fairly
small sample sizes and retrospective data. Strengths of the study
include the use of matched pairs and the comparison of CMT in
psychosis to other mental health disorders instead of the general
population. Future research is needed to explore possible causal
directions, developmental sequences and mediating or moderating
factors on the relationship between CMT and psychosis, as well as a
prospective and longitudinal design. We conclude that CMT might
have an especially strong effect on the development of psychosis, and
assessment of trauma history should be included in psychosis
interventions.
O10.8 12-Year follow-up study of mortality due to suicide among ﬁrst
episode psychosis cohort: is the early intervention program more
effective in reducing excess mortality due to suicide in psychosis
Kit Wa Sherry Chan*1, Wing Yan Stephanie Chan1, Lai Ming Christy Hui1,
Wing Chung Chang1, Ho Ming Edwin Lee1, Yu Hai Eric Chen1
1The University of Hong Kong, Hong Kong¸ China
Background: The mortality gap between the general public and people
with psychotic disorders remains large. Despite the excess mortality
particularly due to suicide observed in people with psychosis, little has
been done to investigate measures that may effectively prevent
premature deaths. It remains unclear if early intervention (EI) for
psychosis can have sustainable effect to prevent excess mortality. This
study compared the mortality rates at 12-year between ﬁrst-episode
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psychosis patients from the EI program, and those who received
standard care service.
Methods: Seven hundred consecutive patients who received the EI
service between 2001 and 2003 in Hong Kong, and 700 matched
patients who received the standard care (SC) service between 1998
and 2001 were traced over a 12-year period following their ﬁrst
presentation. The EI service in Hong Kong (EASY) provides phase
speciﬁc intervention to patients with ﬁrst episode psychosis of age
15–25. All deaths within the cohort were identiﬁed via the centralized
digital patient records system. Ofﬁcial verdict on cause of death was
then obtained from the Coroner’s Court.
Results: Of all 1,400 patients, 80 (5.7%) people had died within the
follow-up period, 74 (5.3%) cases committed suicide. There were 4.1%
(N= 29) among the EI group and 7.3% (N= 51) among the SC group.
The difference of suicide rates between the two groups was
statistically signiﬁcant, χ2 (1) = 4.71, Po0.03. Multivariate Cox-
proportional hazards regression analysis revealed that, EI patients
were at reduced risk of mortality than those in the SC group (adj. rate
ratio [RR] 1.68, 95% CI 1.05–2.69). However, when suicide occurred
within the ﬁrst three years following the initial onset were excluded,
there was no signiﬁcant difference between the two groups (adj. rate
ratio [RR] 1.08, 95% CI.60–1.97), with 1.5% (N=21) from the EI group
and 1.5% (N= 22) from the SC group. Compared with the general
population, the standardized mortality ratios for suicide [SMR] for EI
(SMR 31.5, 95% CI 21.52–44.71) and SC (SMR 51.4, 95% CI 38.64–66.99)
were both very high.
Discussion: This study investigated mortality among 1,400 individuals
with ﬁrst-episode psychosis at 12-year follow-up. Signiﬁcantly more
deaths were observed within people in the EI program than in those
who received the SC service. After controlling for the gender
difference, the analyses revealed that the EI program is more effective
than the SC service in reducing mortality rates in psychosis patients,
especially for the ﬁrst three years of illness. However, the excess
mortality in psychosis patients yet remains large. These points to the
need in reﬁning the EI service in targeting the tractable clinical and
social risk factors that underlie excess mortality in psychosis.
O11. Brain imaging-ii: molecules, structures, and functions
O11.1 Aberrant salience and dysfunctional neural processing of self-
reference in unmedicated schizophrenia patients
Teresa Katthagen*1, Jakob Kamniski1, Norbert Kathmann2, Henrik Walter1,
Andreas Heinz1, Florian Schlagenhauf3
1Campus Charité Mitte, Charité - Universitätsmedizin, Berlin, Germany,
2Humboldt-Universität zu Berlin, Berlin, Germany, 3Campus Charité Mitte,
Charité - Universitätsmedizin; Max Planck Institute for Human Cognitive
and Brain Sciences
Background: A disturbed sense of self is a core symptom in
schizophrenia and can be experimentally probed via self-referential
processing (Kelley et al., 2002; Nelson, Whitford, Lavoie, & Sass, 2014).
The latter process is accompanied by activation in the cortical midline
structures (van der Meer, Costafreda, Aleman, & David, 2010). Previous
work revealed blunted ventromedial prefrontal cortex/anterior cingu-
late cortex (vmPFC/ACC) activation during self-referential processing
correlated with aberrant salience attribution towards irrelevant events
in patients with schizophrenia (Pankow, et al., 2015). However, since
these patients were medicated studies in unmedicated patients are
warranted. To our knowledge, this is the ﬁrst study to investigate
aberrant salience and the neural correlates of self-referential proces-
sing in unmedicated schizophrenia patients.
Methods: In the present study, 18 schizophrenia patients (mean age:
34.83 years, 6 females) who did not receive antipsychotic medication
as well as 18 healthy controls (mean age: 33.44 years, 6 females)
completed the self-referential paradigm during fMRI. In this task, they
applied trait words to themselves (self) or to Angela Merkel (other).
Outside the scanner, they completed the Salience attribution test
(SAT; Roiser et al., 2009), an instrumental learning paradigm probing
aberrant salience. The latter was deﬁned as the individual reaction
time difference between trials of equally irrelevant cue features.
Parameter estimates from the t-contrast self4other were extracted
using an ACC/vmPFC mask and correlated with aberrant salience
scores in each group.
Results: Schizophrenia patients displayed increased aberrant salience
compared to healthy controls (t(32) = 3.132, P=0.004). In the fMRI
paradigm, the t-contrast self4other revealed the typical response
pattern comprising the anterior cortical midlines structures and the
midbrain (at pFWE corrected o .05). In this contrast, groups differed in
their vmPFC response ([338–2], F (1, 68) = 17.20, pSVC for bilateral
ACC/vmPFC= 0.026). Post hoc t-test revealed that unmedicated
schizophrenia patients displayed reduced vmPFC activation compared
to healthy controls ([338–2], t (1, 68) = 4.15, pSVC for bilateral ACC/
vmPFC= 0.013). There was a statistical trend for the negative
correlation between vmPFC/ACC activation and aberrant salience in
schizophrenia patients (r=− 0.411, P= 0.09).
Discussion: Similar to results in medicated patients (Pankow et al.,
2015), unmedicated schizophrenia patients showed increased aber-
rant salience and dysfunctional self-referential processing in the
vmPFC/ACC. Thus, the differentiation of relevance attribution during
self-compared to other-referencing might be blunted in unmedicated
schizophrenia patients. In line with the aberrant salience hypothesis
(Heinz, 2002; Kapur, 2003, 2005), unmedicated patients attributed
meaningfulness to irrelevant events. However, the association
between aberrant salience and self-referential processing did not
approach signiﬁcance which might have been due to the relatively
small sample size. Our results stress the importance of investigating
schizophrenia related concepts at varying clinical stages of the
disorder. Future studies should focus on the idionsycratic aspects and
underlying mechanisms of aberrant salience and self-reference.
O11.2 Single dose of cannabidiol attenuates neurofunctional
abnormalities present in individuals at high risk of psychosis
Sagnik Bhattacharyya*1, Cathy Davies1, Robin Wilson1, Elizabeth Appiah-Kusi1,
Matthijs Bossong1, Paul Allen1, Vincent Giampietro1, Philip McGuire1
1King's College London, London, UK
Background: Cannabidiol (CBD), a major ingredient in the extract of
cannabis, may have antipsychotic and anxiolytic properties.1–3 It may
also protect from impairments in memory induced by delta-9-
tetrahydrocannabinol and has been shown to modulate the neural
substrates of verbal memory in healthy individuals.2 However, the
precise mechanism underlying the potential antipsychotic-like effects
of CBD is unclear. Here, we investigate this in individuals at ultra-high
risk of psychosis (UHR), using a combination of acute pharmacological
challenge and functional magnetic resonance imaging (fMRI). UHR
individuals experience low-grade psychotic symptoms and have a
very high-risk of making a transition to frank psychosis. Our objective
was to test whether an acute oral dose of CBD can modulate
functioning of the neural substrates of verbal memory in individuals at
UHR of psychosis using functional magnetic resonance imaging (fMRI).
Methods: We employed a randomized, double-blind, placebo-con-
trolled, parallel-arm, between-subject design to examine the acute
effect of CBD in 28 UHR individuals who were randomized to receive
either an acute oral dose of CBD (600 mg; UHR-CBD) or placebo (UHR-
Placebo; n= 14 per arm). A separate healthy control group (n= 19) was
studied under identical conditions but without any drug administra-
tion. Each participant was studied on one occasion using fMRI whilst
performing a verbal paired associates learning task.
The outcome measures of interest were regional brain activation
(blood-oxygenation-level-dependent response) during encoding
and recall conditions of the verbal paired associates learning task,
recall performance in the task, and levels of positive psychotic
symptomology.
Results: Relative to healthy controls, UHR subjects under placebo
conditions displayed enhanced engagement (Po0.005) in the
parahippocampal gyrus, inferior parietal lobule, precuneus and
caudate head during the encoding condition, and attenuation of
engagement (Po0.005) of the parahippocampal gyrus and inferior
frontal gyrus during cued recall. Severity of psychotic symptoms in the
UHR individuals under placebo condition were correlated with recall
task performance (r=0.7, P= 0.002) and functional alterations in the
parahippocampal gyrus (rho = 0.58, P=0.018) and caudate (rho = 0.53,
P= 0.031). Acute Cannabidiol treatment in UHR individuals modulated
activation in each of these regions (Po0.005), such that activation
in the UHR-CBD group was intermediate between that of healthy
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